Sowell Financial Services’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History
Bought
Maintained
Sold
Other funds holding LABD
VF
HF
TRCT
CG
FTUS
Sowell Financial Services's LABD Position: Q2 2021 in Review
Sowell Financial Services sold out of Direxion Daily S&P Biotech Bear 3X ETF (LABD) in Q2 2021, closing a stake of 264 shares — an estimated $67K sold.
Sowell Financial Services first reported a position in LABD in Q1 2020 and held it in 3 quarters. The position peaked at $67K in Q1 2021. 18 funds tracked by Wall St. Rank hold LABD as of Q2 2021.
- Sowell Financial Services reported no remaining Direxion Daily S&P Biotech Bear 3X ETF position as of Q2 2021 after selling out during the quarter.
- Sowell Financial Services sold 264 Direxion Daily S&P Biotech Bear 3X ETF shares in Q2 2021, an estimated $67K.
- Sowell Financial Services first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q1 2020 and held it in 3 quarters.
- Sowell Financial Services's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $67K in Q1 2021.
- 18 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q2 2021.
Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.